Magnolia bark and cortisol: what the research says
This article is part of our Cortisol & Stress: The Complete Guide.
Short answer: Magnolia bark and cortisol has two small human trials behind it, and they disagree. One found salivary cortisol 18% lower than placebo after 4 weeks, the other found no significant cortisol change. Both tested a branded magnolia and phellodendron combination, not magnolia alone. CortiSync lists 100 mg of magnolia bark extract per 2-capsule serving, so treat it as one supportive ingredient in a seven-herb blend, not a proven cortisol lever. See the official CortiSync page for current terms.
Affiliate disclosure: we may earn a commission from links on this page at no extra cost to you. This does not change what we write.
By Healthy Supplements Editorial Team · Last checked November 15, 2026
Magnolia is the ingredient on the CortiSync label that people ask about least and understand least. Everyone has heard of ashwagandha, but few readers know what a magnolia bark extract is meant to do, or whether magnolia bark and cortisol has been studied in people at all. We read the official product page on November 15, 2026, re-read the Supplement Facts image, opened the trial papers in Europe PMC, and kept only what they say. We focused on magnolia bark and cortisol because that is the claim readers meet most often.
If you are new to the formula, start with our complete CortiSync guide, which maps every article we have on it, and our cortisol guide for the basics. This page answers one narrow question: what do we actually know about magnolia bark and cortisol, and what does that mean for the 100 mg on the CortiSync label?

Magnolia bark and cortisol: what the research can and cannot say
Here is the honest summary before the details. A title search of Europe PMC for magnolia and cortisol on November 15, 2026 returned exactly one paper, a 2013 trial. A second human trial from 2008 measured cortisol among other outcomes. Between them they give one positive and one null cortisol result. That is not enough to say magnolia bark and cortisol is a reliable link, and it is not nothing either.
The word to watch is “branded.” Both trials tested Relora, a patented combination of Magnolia officinalis and Phellodendron amurense barks. Neither isolated magnolia. So when a page says magnolia lowers cortisol, the fair translation is: a magnolia and phellodendron combination did so in one small, manufacturer-funded trial and did not in another. Anyone selling magnolia bark and cortisol as settled science is skipping that step.
What CortiSync says about magnolia and what the label shows
On the official page we read on November 15, 2026, the manufacturer states that magnolia is a tree with active compounds shown to help promote sleep, reduce stress and regulate cortisol function. The page does not name the trial behind that sentence. That matters, because the only trials we found measured a different product.
The Supplement Facts image, which we read on the same date, gives the actual numbers. The serving size is 2 capsules and the bottle holds 30 servings. Magnolia is the sixth ingredient by weight, and the label does not say what the extract is standardized to.
| Ingredient (per 2 capsules) | Amount on the label | Label detail |
|---|---|---|
| Sensoril ashwagandha root extract | 300 mg | Branded extract |
| Lemon balm herb powder | 150 mg | Melissa officinalis |
| Lichi fruit extract | 120 mg | Lychee chinensis |
| L-theanine | 100 mg | Amino acid from tea |
| Holy basil leaf extract | 100 mg | Standardized to 2% ursolic acid |
| Magnolia bark extract | 100 mg | Magnolia officinalis, no standardization stated |
| Rhodiola rosea root extract | 50 mg | 3% rosavins, 1% salidroside |
Two things stand out for anyone researching magnolia bark and cortisol. First, the label says “bark” and names the species, which is the right plant part for the neolignans discussed below, and it is the plant part that matters for magnolia bark and cortisol. Second, there is no phellodendron anywhere on the panel, so the combination used in the trials is not what the bottle contains. Our CortiSync ingredients research page goes through the other six herbs one by one.
The 2013 trial: the one result on magnolia bark and cortisol
The best-known paper is Talbott and colleagues, published in 2013 in the Journal of the International Society of Sports Nutrition (PubMed 23924268; full text on PMC3750820). We opened the abstract and the full text. It enrolled 56 adults, 35 men and 21 women, screened for moderate stress, and compared Relora with a look-alike placebo for 4 weeks.
Subjects took 500 mg a day, split into 250 mg at breakfast and 250 mg at dinner. The extract was standardized to not less than 1.5% honokiol and 0.1% berberine. Berberine comes from the phellodendron half of the product, which is another reminder that this was a combination, not magnolia bark and cortisol in isolation.
The headline result: at week 4, salivary cortisol was 18% lower in the Relora group than in the placebo group, and the difference was statistically significant. Mood scores moved in the same direction, with overall stress and global mood state both about 11% better than placebo. The authors reported no adverse events, and body weight and body fat did not change significantly. The abstract also reports lower fatigue and higher vigor. That single number is the whole case for magnolia bark and cortisol so far.
Why this trial is encouraging but not decisive
It is a randomized, placebo-controlled design, which is the right format. But it is small, it ran for only 4 weeks, and the paper states it was funded by the manufacturer of Relora and conducted by SupplementWatch, with some authors employed there. The authors say they have no direct financial relationship with the manufacturer, but industry funding is still a reason to hold the 18% figure loosely. A single 56-person study is a lead, and the honest label for it is “worth replicating.”
The 2008 trial: where cortisol did not move
The earlier paper is Kalman and colleagues, published in 2008 in Nutrition Journal (PubMed 18426577). It was a pilot, double-blind, placebo-controlled study of Relora in healthy, overweight premenopausal women aged 20 to 50 who tended to eat more under stress. The dose was 250 mg capsules three times daily for 6 weeks.
Forty people were in the intent-to-treat group and 26 finished. Relora beat placebo on the Spielberger state anxiety questionnaire, which measures temporary, situational anxiety. It did not beat placebo on the trait questionnaire, which measures long-standing anxiety. And the outcome that matters here: salivary cortisol and amylase, appetite, body measurements and sleep quality were not significantly changed compared with placebo. The authors concluded Relora may offer some relief for mild transitory anxiety, and reported no significant adverse events.
Put the two papers side by side and the picture for magnolia bark and cortisol is honest but unglamorous: a different population, a different dose, a different length, and opposite cortisol results. Small samples, drop-outs and different saliva-sampling schedules can all produce that kind of split. It does not prove magnolia does nothing, and it does not prove it works. The 2008 paper does not support magnolia bark and cortisol as a dependable pairing.
Label dose versus trial dose: the gap in numbers
This is the part most product pages leave out. We put the doses next to each other so you can see how far the CortiSync label sits from what was tested.
| 2013 trial (Talbott) | 2008 trial (Kalman) | CortiSync label | |
|---|---|---|---|
| What was taken | Relora: magnolia + phellodendron | Relora: magnolia + phellodendron | Magnolia officinalis bark extract inside a 7-herb blend |
| Daily amount | 500 mg combined | 750 mg combined (250 mg three times daily) | 100 mg of magnolia bark extract |
| Length | 4 weeks | 6 weeks | Directions: 2 capsules daily with a meal |
| People | 56 stressed adults | 40 enrolled, 26 finished | Not applicable: no CortiSync trial found |
| Cortisol result | Salivary cortisol 18% lower than placebo | No significant change | Not measured |
The trials used combined bark extracts, and the papers we read do not break out how much of each dose was magnolia. So we cannot say that 100 mg of magnolia bark extract is more, less or equal to the magnolia in either trial. What we can say is that the CortiSync figure is a fraction of the combined daily amount tested, and that the label does not state a honokiol or magnolol percentage. Anyone claiming the label dose “matches the research” on magnolia bark and cortisol is guessing. The gap matters for any claim about magnolia bark and cortisol.
That does not make the formula pointless. A blend can be designed so each herb contributes a modest amount, and the other ingredients have their own trials, such as the ones we cover in our Sensoril ashwagandha article and our holy basil article. But it does mean the magnolia line cannot carry the cortisol claim by itself.
Honokiol, magnolol and why extracts differ
Magnolia bark extract is valued for two neolignans, magnolol and honokiol. A 2018 safety review in Planta Medica (PubMed 29925102) explains that the content of these compounds depends on the Magnolia species, the area of origin, the part of the plant used and the preparation method. In plain terms, two bottles that both say “magnolia bark” can contain different amounts of the active compounds.
That is why standardization matters on a label. The Relora used in the 2013 trial stated a minimum honokiol percentage. The CortiSync panel we read does not. We are not saying the product lacks honokiol, only that the label gives you no way to check, which is a fair question to put to the manufacturer.
There is a second limitation. A 2026 review of honokiol in Biomedical Reports (PubMed 42488747) summarized 99 studies and notes that clinical use of honokiol is restricted by its poor water solubility and low oral bioavailability. Most of that literature is lab and animal work. So even a good result in a dish says little about what a 100 mg capsule does in a person, which is another reason to keep the claims about magnolia bark and cortisol modest. Keep that in mind whenever a page treats magnolia bark and cortisol as settled.
Is magnolia bark safe? What the reviews say
The 2018 review reports that concentrated magnolia bark extract showed no mutagenic or genotoxic potential in the studies it covered, and that a subchronic study established a no-adverse-effect level. It adds that intervention trials using concentrated extract for up to one year did not report adverse effects, and that food safety authorities have evaluated magnolol and honokiol and considered them safe. The safety picture for magnolia bark and cortisol products is reassuring but incomplete, and the cortisol question is separate from the safety question.
The same review is careful about one thing we should repeat: like other dietary polyphenols, magnolol and honokiol are metabolized by glucuronidation, and an interaction with pharmaceutical drugs or other herbal ingredients cannot be excluded. It also notes the traditional use of magnolia bark for sedative effects. Combine those two facts and the sensible message is practical rather than alarming: if you take prescription medicines, especially sedatives, tell your prescriber about every supplement.
General supplement guidance points the same way. NCCIH says supplements can interact with prescription drugs, pose risks with some medical conditions and affect bleeding or anesthesia before surgery (NCCIH, using dietary supplements wisely). The NIH Office of Dietary Supplements adds that side-effect risk is highest at high doses, when supplements replace prescribed medicine, or when several are combined (ODS, dietary supplements: what you need to know). A seven-herb blend is, by definition, several at once. Our who should not take CortiSync and CortiSync safety questions pages cover the practical cautions.
Who should skip it or ask first
Anyone who is pregnant or breastfeeding should ask a clinician first. NCCIH notes many supplements have not been tested in pregnant or nursing women, and we found no pregnancy data for magnolia bark and cortisol in the pages we opened. People who take sedatives, blood-pressure or blood-sugar medicines, or who have a liver condition, should also check first. And if you are scheduled for surgery, tell the surgical team about the supplement, as NCCIH advises.
Also pause before assuming your cortisol is the problem. NIDDK describes Cushing syndrome as the result of too much cortisol over a long period, most often from long-term use of steroid medicines, with signs such as weight gain, a rounded face, easy bruising and weak muscles (NIDDK, Cushing syndrome). The same page notes that some people have high cortisol on and off with depression, anxiety, heavy drinking or poorly controlled diabetes. A supplement is not a diagnostic step. If you have those signs, see a clinician rather than experimenting. None of this changes the advice on magnolia bark and cortisol: talk to a clinician first.
Putting cortisol in perspective
It is easy to treat cortisol as a villain to be lowered. It is a normal hormone that helps regulate blood pressure, blood sugar and inflammation, and the goal of any stress plan is balance, not zero. NCCIH describes long-term stress as linked to digestive problems, headaches and sleep disorders, and reports that relaxation techniques such as slow deep breathing are associated with modest reductions in blood pressure and cortisol (NCCIH, stress). NIMH lists exercise, a steady sleep routine, less caffeine and journaling among helpful steps (NIMH, stress fact sheet).
So the realistic way to read magnolia bark and cortisol is as one small, supportive piece inside a wider routine. If you want to go deeper on daily habits, see our cortisol supplement questions page and our guide on how to choose a cortisol supplement. For an ingredient with a stronger human data set, our magnesium and cortisol article is a useful comparison.
How magnolia fits with the other six ingredients
CortiSync does not rely on magnolia. The label also lists Sensoril ashwagandha at 300 mg, lemon balm at 150 mg, lichi at 120 mg, L-theanine at 100 mg, holy basil at 100 mg and rhodiola at 50 mg. For context, NCCIH says ashwagandha is possibly safe short term and that evidence for stress is mixed (NCCIH, ashwagandha), and that there is not enough reliable evidence that rhodiola helps any health purpose (NCCIH, rhodiola). We include those lines so you can see that the whole formula, not only magnolia bark and cortisol, is a supportive blend with uneven evidence.
Practical questions follow from that. How long should you run it before judging? See how long to take CortiSync. Does coffee matter? See CortiSync with coffee. Would drops be better? See cortisol drops versus pills. And what is the label dose guidance? See CortiSync dosage.
Our verdict on magnolia bark and cortisol
If the question is “does magnolia bark lower cortisol,” the honest answer is: maybe, in a branded combination, in one small funded trial, and not in a second one. If the question is “is the 100 mg in CortiSync a proven cortisol dose,” the answer is no, because no trial tested that dose, that extract or that formula. If the question is “is it a reasonable ingredient in a blend that also includes better-studied herbs,” that is a fair view, as long as you accept it as an ingredient-level judgment and not a promise about the finished product. In one line, magnolia bark and cortisol is a promising question, not a closed one.
What helps turn interest into a good decision is the manufacturer’s terms. On the official page we read on November 15, 2026, the manufacturer states a 67-day guarantee, and the directions are 2 capsules daily with a meal. Those are the manufacturer’s statements, so confirm the current offer before you order.
Check the official CortiSync terms
What to check on the label before you buy
- The species and plant part: Magnolia officinalis bark, which matches the research on magnolol and honokiol.
- The claim: ask which trial supports any statement about magnolia bark and cortisol.
- Standardization: ask whether honokiol or magnolol is quantified, since the panel we read does not say.
- Every other ingredient: with seven herbs, check each against your medicines and conditions.
- The serving: 2 capsules, 30 servings per bottle, daily value not established for these plants.
- The terms: the guarantee length and what it covers, as stated on the official page on the day you order.
Frequently asked questions about magnolia bark and cortisol
These are the questions readers ask most about magnolia bark and cortisol.
Does magnolia bark lower cortisol?
The evidence is thin and mixed. A 2013 trial of 56 moderately stressed adults found salivary cortisol 18% lower than placebo after 4 weeks on Relora, a branded magnolia and phellodendron combination. A 2008 pilot trial in women found no significant change in salivary cortisol. Neither tested magnolia bark alone, so magnolia bark and cortisol is still an open question.
How much magnolia bark is in CortiSync?
The Supplement Facts panel we read on November 15, 2026 lists 100 mg of Magnolia officinalis bark extract per serving of 2 capsules. It does not state a standardization such as a honokiol percentage.
Is the CortiSync dose the same as the trial dose?
No. The 2013 trial used 500 mg a day of a magnolia and phellodendron combination, and the 2008 trial used 750 mg a day. CortiSync lists 100 mg of magnolia bark extract only, inside a seven-ingredient blend, so the label amount cannot be matched to either trial.
What are honokiol and magnolol?
They are the two main neolignans in magnolia bark extract. A 2018 review says their content depends on the species, origin, plant part and preparation method, which is why two magnolia extracts can differ.
Is magnolia bark safe?
A 2018 safety review found no genotoxic potential for concentrated magnolia bark extract and noted that intervention trials of up to one year reported no adverse effects. It also says an interaction with medicines or other herbs cannot be excluded, so ask a clinician if you take prescriptions.
Does magnolia bark make you sleepy?
The 2018 review describes traditional use of magnolia bark for sedative effects, and CortiSync is taken with a meal rather than at a set time. If you feel drowsy, treat that as information and talk to a clinician before driving or combining it with sedatives.
Can magnolia bark replace treatment for high cortisol?
No. NIDDK explains that long-term high cortisol can have medical causes such as Cushing syndrome. A supplement is not a way to diagnose or treat that, and persistent symptoms deserve a medical check.
Should pregnant or breastfeeding women take it?
NCCIH notes that many supplements have not been tested in pregnant or nursing women. We found no magnolia bark safety data for pregnancy in the pages we opened, so the cautious answer is to ask a clinician first.
What does the manufacturer say about magnolia and cortisol?
On the official page we read on November 15, 2026, the manufacturer states that magnolia has compounds shown to help promote sleep, reduce stress and regulate cortisol function. That is a manufacturer claim, and the page does not cite a specific trial for it.
Is there a trial of CortiSync itself?
A title search of Europe PMC for magnolia and cortisol on November 15, 2026 returned one paper, the 2013 Relora trial. We did not find a published trial of the CortiSync formula in our searches, so the evidence here is about ingredients, not the finished product.
Sources we opened
Every source behind this page on magnolia bark and cortisol is listed below.
- PubMed 23924268: Talbott 2013, Relora, cortisol and mood
- PMC3750820: full text of the 2013 trial (dose, funding, results)
- PubMed 18426577: Kalman 2008, Relora in healthy women
- PubMed 29925102: safety and toxicology of magnolol and honokiol, 2018
- PubMed 42488747: honokiol review, 2026
- NCCIH: using dietary supplements wisely
- NCCIH: stress
- NCCIH: rhodiola
- NCCIH: ashwagandha
- NIH ODS: dietary supplements, what you need to know
- FDA: dietary supplements
- MedlinePlus: dietary supplements
- NIDDK: Cushing syndrome
- NIMH: stress fact sheet
- Official CortiSync page, read November 15, 2026

See the official CortiSync page
Medical disclaimer: This article is for general information and is not medical advice. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Talk to a qualified health professional before starting, continuing or stopping any supplement, especially if you are pregnant, breastfeeding, have a medical condition or take medicines.






